Nuwellis outlines Q3 recovery and strategic shift after resolving $400,000 back order
Source: SeekingAlpha
2025-08-14 14:38:14 ET
More on Nuwellis
- Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript
- Nuwellis prices public offering of stock and warrants; shares down over 37%
- Financial information for Nuwellis
Read the full article on Seeking Alpha
For further details see:
Nuwellis outlines Q3 recovery and strategic shift after resolving $400,000 back order
Nuwellis Inc.
NASDAQ: NUWE
NUWE Trading
-8.03% G/L:
$1.1801 Last:
77,871 Volume:
$1.325 Open:
NUWE Latest News
March 10, 2026 08:15:00 am
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026 08:00:00 am
Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy
February 26, 2026 08:00:00 am
Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors
NUWE Stock Data
$4,769,055
1,855,153
4.24%
7
N/A
Medical Equipment & Supplies
Healthcare
US
Eden Prairie
